Physician

Hematology

Dr. Piernicola Boccuni, MD

Piernicola Boccuni practices Hematology. Piernicola Boccuni is a published doctor. He published 24 publications, including: 'CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies.'

Publications

Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin''s ly...
Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycle.
Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.
Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.
Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.
Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation.
CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies.
Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukaemia.
Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.
The PIG-A gene somatic mutation responsible for paroxysmal nocturnal hemoglobinuria.
Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1.
L3MBTL1, a histone-methylation-dependent chromatin lock.
Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells.
Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential.
Combinatorial action of RUNX1 and PU.1 in the regulation of hematopoiesis.
Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation.
Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Malignant brain tumor repeats: a three-leaved propeller architecture with ligand/peptide binding pockets.
The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6).
Transcription factor fusions in acute leukemia: variations on a theme.

Doctors Specialties

Hematology

Accepted Insurances

Cofinity PPO

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Pawan Gundavaram, MD
	Dr. Andrea L. Amico, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark Karides, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard F. Warren, MD This Doctor is OpenDoctor Recommended.
	Dr. John J. Maciejewski, MD This Doctor is OpenDoctor Recommended.
	Dr. Julia B. Ashenhurst, MD This Doctor is OpenDoctor Recommended.
	Dr. Jamile M. Shammo, MD This Doctor is OpenDoctor Recommended.
	Dr. John L. Kennedy, MD This Doctor is OpenDoctor Recommended.
	Dr. Nagarpu S. Reddy, MD This Doctor is OpenDoctor Recommended.
	Dr. Emily K. Curran, MD
	Dr. Sefer Gezer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Selina L. Chow, MD This Doctor is OpenDoctor Recommended.
	Dr. Sangeetha Reddy, MD This Doctor is OpenDoctor Recommended.
	Dr. Pritesh R. Patel, MD This Doctor is OpenDoctor Recommended.
	Irfan Maghfoor, MB